Home/Filings/4/0001683168-20-000807
4//SEC Filing

Matsuda Kazuko 4

Accession 0001683168-20-000807

CIK 0001226616other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 5:53 PM ET

Size

5.2 KB

Accession

0001683168-20-000807

Insider Transaction Report

Form 4
Period: 2020-03-13
Matsuda Kazuko
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2020-03-13$3.62/sh+2,000$7,240111,476 total
Footnotes (2)
  • [F1]The reported shares were purchased in multiple transactions. The purchase price reported in Column 4 is a weighted average price ranging from $3.54 to $3.69. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]Includes 289 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).

Documents

1 file

Issuer

MEDICINOVA INC

CIK 0001226616

Entity typeother

Related Parties

1
  • filerCIK 0001531140

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:53 PM ET
Size
5.2 KB